Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(34), p. 11509-11509
DOI: 10.1200/jco.2016.34.15_suppl.11509
Links
Tools
Crizotinib in children and adolescents with advanced ROS1, MET, or ALK-rearranged cancer: Results of the AcSé phase II trial.
Journal article published in 2016 by
Gilles Vassal,
Laura Faivre 
,
Birgit Geoerger,
Dominique Plantaz,
Anne Auvrignon,
Carole Coze,
Nathalie Aladjidi,
Nicolas Sirvent,
Arnauld Verschuur,
Gudrun Schleiermacher,
Celine Icher,
Nathalie Auger,
Etienne Lonchamp,
Minckes Odile,
Celine Mahier-Ait Oukhatar
and other authors.
,
Birgit Geoerger,
Dominique Plantaz,
Anne Auvrignon,
Carole Coze,
Nathalie Aladjidi,
Nicolas Sirvent,
Arnauld Verschuur,
Gudrun Schleiermacher,
Celine Icher,
Nathalie Auger,
Etienne Lonchamp,
Minckes Odile,
Celine Mahier-Ait Oukhatar
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 